Chronic Lymphocytic Leukemia Clinical Trials in La Roche-sur-Yon
2 recruitingLa Roche-sur-Yon, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLeukemia, B-cell+1 more
Loxo Oncology, Inc.662 enrolled144 locationsNCT05254743
Recruiting
Determinants of the Response to BTK Degraders (BTKd) in Double Refractory CLL
Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Nantes University Hospital60 enrolled14 locationsNCT07099443